Based on the clinical indications and current guidelines, which of the following is the most appropriate initial or add-on antihypertensive medication class for each patient described below?
- A -year-old woman presents with newly diagnosed hypertension. She has a history of recurrent renal colic, and stone analysis previously showed calcium oxalate. Dual-energy x-ray absorptiometry reveals osteopenia.Thiazide-type diuretic
- A -year-old man with type 2 diabetes mellitus is found to have a blood pressure of mm Hg on three separate occasions. Laboratory testing reveals a spot urine albumin-to-creatinine ratio of mg/g.Angiotensin-converting enzyme inhibitor
- A -year-old man with poorly controlled hypertension experiences reproducible substernal chest pressure upon walking up a flight of stairs, which resolves with rest. His resting electrocardiogram shows normal sinus rhythm at /min.Cardioselective beta-blocker
- A -year-old Black man presents for a routine checkup and is diagnosed with primary hypertension. He has no other medical problems, and his basic metabolic panel and urinalysis are within normal limits.Dihydropyridine calcium channel blocker
Cevap
The correct pairings align the patient's comorbidities with the specific benefits of each antihypertensive class: the patient with nephrolithiasis matches with a thiazide-type diuretic; the diabetic patient with albuminuria matches with an angiotensin-converting enzyme inhibitor; the patient with stable angina matches with a cardioselective beta-blocker; and the Black patient with uncomplicated hypertension matches with a dihydropyridine calcium channel blocker.
Each patient's clinical scenario contains compelling indications for a specific antihypertensive class based on current joint guidelines. Thiazides prevent calcium stones; ACE inhibitors protect diabetic kidneys; beta-blockers relieve angina; and calcium channel blockers are first-line for Black patients with uncomplicated hypertension.
Adım Adım Çözüm
Anahtar Kavram
Selection of antihypertensive medications must be tailored to patient-specific compelling indications, such as comorbidities (e.g., angina, diabetes with albuminuria) and demographic factors, to optimize both blood pressure control and overall outcomes.